J&J boosts US investments by 25% over 4 years amid looming tariff threats
By Bhanvi Satija and Patrick Wingrove (Reuters) – Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a threat of drug import duties by the Trump administration compels companies to expand their manufacturing operations domestically. The pharmaceutical giant said on …
J&J boosts US investments by 25% over 4 years amid looming tariff threats Read More »










